Monday’s Top Health Care Stories: Tesaro, Alnylam, Allergan, and Valeant
Tesaro, Alnylam, Allergan, and Valeant could make waves across the health-care sector this morning.
Biotech of the Week: Opko Health Inc.
Opko Health competes with Laboratory Corporation of America and Quest Diagnostics on the diagnostics side and is partnered with Tesaro on the therapeutics side.
Should You Buy Tesaro After Its Earnings Miss?
Tesaro just missed earnings estimates by $0.37 per share for its first quarter. Is this stock a bad news buy?